Timing of onset affects arthritis presentation pattern in antisyntethase syndrome

Clin Exp Rheumatol. Jan-Feb 2018;36(1):44-49. Epub 2017 Jul 26.

Abstract

Objectives: To evaluate if the timing of appearance with respect to disease onset may influence the arthritis presentation pattern in antisynthetase syndrome (ASSD).

Methods: The patients were selected from a retrospective large international cohort of ASSD patients regularly followed-up in centres referring to AENEAS collaborative group. Patients were eligible if they had an antisynthetase antibody testing positive in at least two determinations along with arthritis occurring either at ASSD onset (Group 1) or during the course of the disease (Group 2).

Results: 445 (70%; 334 females, 110 males, 1 transsexual) out of the 636 ASSD we collected had arthritis, in the majority of cases (367, 83%) from disease onset (Group 1). Patients belonging to Group 1 with respect to Group 2 had an arthritis more commonly polyarticular and symmetrical (p=0.015), IgM-Rheumatoid factor positive (p=0.035), erosions at hands and feet plain x-rays (p=0.036) and more commonly satisfying the 1987 revised classification criteria for rheumatoid arthritis (RA) (p=0.004). Features such as Raynaud's phenomenon, mechanic's hands and fever (e.g. accompanying findings) were more frequently reported in Group 2 (p=0.005).

Conclusions: In ASSD, the timing of appearance with respect to disease onset influences arthritis characteristics. In particular, RA features are more common when arthritis occurs from ASSD onset, suggesting an overlap between RA and ASSD in these patients. When arthritis appears during the follow-up, it is very close to a connective tissue disease-related arthritis. Also, the different prevalence of accompanying features between these two groups is in line with this possibility.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Adult
  • Arthritis / diagnosis
  • Arthritis / epidemiology*
  • Arthritis / immunology
  • Autoantibodies / blood
  • Biomarkers / blood
  • Europe / epidemiology
  • Female
  • Humans
  • Male
  • Mexico / epidemiology
  • Middle Aged
  • Myositis / diagnosis
  • Myositis / epidemiology*
  • Myositis / immunology
  • Phenotype
  • Prevalence
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Time Factors

Substances

  • Autoantibodies
  • Biomarkers

Supplementary concepts

  • Antisynthetase syndrome